Suppr超能文献

降压效果谷峰比的可重复性及临床价值:来自样本研究的证据

Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study.

作者信息

Omboni S, Fogari R, Palatini P, Rappelli A, Mancia G

机构信息

From the Cattedra di Medicina Interna, Ospedale San Gerardo, Monza, Università di Milano, Centro di Fisiologia Clinica e Ipertensione, Ospedale Maggiore, and Istituto Scientifico Ospedale San Luca, Istituto Auxologico Italiano, Milano, Italy.

出版信息

Hypertension. 1998 Sep;32(3):424-9. doi: 10.1161/01.hyp.32.3.424.

Abstract

The objectives of our study were to assess the reproducibility of the trough-to-peak ratio (T/P) and to see whether a high T/P is accompanied by more organ protection or vice versa. The study included 175 (mean+/-SD age, 51+/-9 years) subjects with mild-moderate essential hypertension who had echocardiographic evidence of left ventricular (LV) hypertrophy taken from the SAMPLE study (Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation), an open-label multicenter study. The study included a 3-week washout pretreatment period, a 12-month treatment period with lisinopril (n=84) or lisinopril plus hydrochlorothiazide (n=91) once daily, and a 4-week placebo follow-up period. Results of 24-hour ambulatory blood pressure monitoring and echocardiographic determination of left ventricular mass index (LVMI) were obtained before and after 3 and 12 months of treatment. T/Ps were computed in each patient by dividing the systolic and diastolic blood pressure changes at trough (changes in the last 2 hours of the monitoring period) by those at peak (average of the 2 adjacent hours with the maximal blood pressure reduction between the 2nd and 8th hour from drug intake) after 3 and 12 months of treatment. Average 24-hour blood pressure was similarly reduced at 3 and 12 months. Trough blood pressure changes at 3 and 12 months were closely correlated, as were the corresponding peak blood pressure changes. However, the 3- and 12-month T/Ps correlated to a lesser degree (r<0.42). Furthermore, the reduction of LVMI induced by treatment was similarly correlated with the treatment-induced reduction in 24-hour average, trough, and peak blood pressures but not with the T/Ps. This was also evident when the contribution to LV hypertrophy regression by 24-hour blood pressure changes and T/Ps was assessed in a multivariate regression analysis. In patients with a T/P >/=0.5 or <0.5, the regression of LVMI was similar. In conclusion, peak and trough blood pressure changes are reproducible and predict the regression of LVMI induced by treatment as well as average 24-hour blood pressure. T/Ps are less reproducible, and their value does not predict regression of organ damage by antihypertensive treatment.

摘要

我们研究的目的是评估谷峰比值(T/P)的可重复性,并观察高T/P是否伴随着更多的器官保护作用,反之亦然。该研究纳入了175名(平均±标准差年龄,51±9岁)患有轻中度原发性高血压的受试者,这些受试者有左心室(LV)肥厚的超声心动图证据,数据来自SAMPLE研究(动态血压监测与赖诺普利评估研究),这是一项开放标签的多中心研究。该研究包括一个为期3周的洗脱预处理期、一个为期12个月的每日一次服用赖诺普利(n = 84)或赖诺普利加氢氯噻嗪(n = 91)的治疗期,以及一个为期4周的安慰剂随访期。在治疗3个月和12个月前后,获取了24小时动态血压监测结果以及左心室质量指数(LVMI)的超声心动图测定结果。在治疗3个月和12个月后,通过将谷值(监测期最后2小时的变化)时的收缩压和舒张压变化除以峰值(服药后第2至8小时之间血压降幅最大的相邻2小时的平均值)来计算每位患者的T/P。在3个月和12个月时,24小时平均血压同样降低。3个月和12个月时的谷值血压变化密切相关,相应的峰值血压变化也是如此。然而,3个月和12个月时的T/P相关性较小(r<0.42)。此外,治疗引起的LVMI降低与治疗引起的24小时平均血压、谷值血压和峰值血压降低相似相关,但与T/P无关。当在多变量回归分析中评估24小时血压变化和T/P对LV肥厚消退的贡献时,这一点也很明显。在T/P≥0.5或<0.5的患者中,LVMI的消退情况相似。总之,峰值和谷值血压变化具有可重复性,可预测治疗引起的LVMI消退以及24小时平均血压。T/P的可重复性较差,其值不能预测降压治疗对器官损伤的消退情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验